My Treatment Approach: Hormone Receptor-Positive Breast Cancer

home / insights / my-treatment-approach-hormone-receptor-positive-breast-cancer

Expert oncologists discuss the hormone receptor–positive (HR+) breast cancer treatment landscape and their suggested approaches to treating patients in both the early and metastatic disease settings.

EP. 1: HR+ Breast Cancer: Incidence, Prognosis, and Risk Stratification

Massimo Cristofanilli, MD, FACP;Sara M. Tolaney, MD, MPH
January 16th 2023

EP. 2: Patient Profile 1: A 56-Year-Old Woman with Early HR+ Breast Cancer

Massimo Cristofanilli, MD, FACP;Sara M. Tolaney, MD, MPH
January 16th 2023

EP. 3: Abemaciclib Plus Adjuvant Endocrine Therapy in Breast Cancer

Massimo Cristofanilli, MD, FACP;Sara M. Tolaney, MD, MPH
January 23rd 2023

EP. 4: Clinical Insights on the Use of Adjuvant Therapy Plus Abemaciclib in HR+ Breast Cancer

Massimo Cristofanilli, MD, FACP;Sara M. Tolaney, MD, MPH
January 23rd 2023

EP. 5: Patient Profile 2: A 62-Year-Old Woman with Metastatic HR+ Breast Cancer

Massimo Cristofanilli, MD, FACP;Sara M. Tolaney, MD, MPH
January 30th 2023

EP. 6: Overview of Treatment Options for Patients with Breast Cancer

Massimo Cristofanilli, MD, FACP;Sara M. Tolaney, MD, MPH
January 30th 2023

EP. 7: The Role of Surgery in Breast Cancer

Massimo Cristofanilli, MD, FACP;Sara M. Tolaney, MD, MPH
February 6th 2023

EP. 8: Treatment after Progression on CDK4/6 Inhibitors

Massimo Cristofanilli, MD, FACP;Sara M. Tolaney, MD, MPH
February 6th 2023
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact